Robert C. Faulkner - 14 Apr 2023 Form 3 Insider Report for Augmedix, Inc.

Role
Director
Signature
/s/ Robert Faulkner
Issuer symbol
N/A
Transactions as of
14 Apr 2023
Net transactions value
$0
Form type
3
Filing time
21 Apr 2023, 21:30:39 UTC
Previous filing
25 May 2022
Next filing
15 May 2023

No securities are beneficially owned.

Remarks:

Robert Faulkner is a managing director of Redmile Group, LLC ("Redmile"), and was elected to the Issuer's board of directors as a representative of Redmile. As a result, each of Redmile, Jeremy Green, as principal of Redmile, RedCo I, L.P. and Redmile Private Investments II, L.P. is a director by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.